Citius Pharmaceuticals, Inc. Reports Fiscal Second Quarter 2024 Financial Results and Provides Business Update
PremiumPress ReleasesCitius Pharmaceuticals, Inc. Reports Fiscal Second Quarter 2024 Financial Results and Provides Business Update
2M ago
Citius Pharmaceuticals to sell 21.4M shares at 70c in registered direct offering
PremiumThe Fly
Citius Pharmaceuticals to sell 21.4M shares at 70c in registered direct offering
3M ago
Citius Pharmaceuticals’ lymphir Phase 1 trial adds City of Hope site
PremiumThe Fly
Citius Pharmaceuticals’ lymphir Phase 1 trial adds City of Hope site
4M ago
Citius Pharmaceuticals Resubmits LYMPHIR™ License Application
PremiumCompany AnnouncementsCitius Pharmaceuticals Resubmits LYMPHIR™ License Application
6M ago
Citius announces resubmission of BLA to FDA forLYMPHIR
PremiumThe Fly
Citius announces resubmission of BLA to FDA forLYMPHIR
6M ago
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
7M ago
Biotech Alert: Searches spiking for these stocks today
PremiumThe FlyBiotech Alert: Searches spiking for these stocks today
9M ago
Citius executes definitive agreement to merge subsidiary with TenX Keane
PremiumThe Fly
Citius executes definitive agreement to merge subsidiary with TenX Keane
9M ago
Citius Pharmaceuticals Executes Definitive Agreement to Merge Wholly Owned Subsidiary with TenX Keane Acquisition to Form Publicly Listed Citius Oncology, Inc.
PremiumPress Releases
Citius Pharmaceuticals Executes Definitive Agreement to Merge Wholly Owned Subsidiary with TenX Keane Acquisition to Form Publicly Listed Citius Oncology, Inc.
9M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100